Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class

Micah Rapp, Yicheng Guo, Eswar R. Reddem, Lihong Liu, Pengfei Wang, Jian Yu, Gabriele Cerutti, Jude Bimela, Fabiana Bahna, Seetha Mannepalli, Baoshan Zhang, Peter D. Kwong, David D. Ho, Lawrence Shapiro, View ORCID ProfileZizhang Sheng
doi: https://doi.org/10.1101/2021.01.11.426218
Micah Rapp
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lss8@columbia.edu zs2248@cumc.columbia.edu
Yicheng Guo
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lss8@columbia.edu zs2248@cumc.columbia.edu
Eswar R. Reddem
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lihong Liu
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pengfei Wang
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Yu
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriele Cerutti
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jude Bimela
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiana Bahna
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seetha Mannepalli
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baoshan Zhang
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter D. Kwong
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David D. Ho
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Shapiro
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
4Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lss8@columbia.edu zs2248@cumc.columbia.edu
Zizhang Sheng
2Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA
3Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zizhang Sheng
  • For correspondence: lss8@columbia.edu zs2248@cumc.columbia.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

SUMMARY

Antibodies with heavy chains that derive from the VH1-2 gene constitute some of the most potent SARS-CoV-2-neutralizing antibodies yet identified. To provide insight into whether these genetic similarities inform common modes of recognition, we determined structures of the SARS-CoV-2 spike in complex with three VH1-2-derived antibodies: 2-15, 2-43, and H4. All three utilized VH1-2-encoded motifs to recognize the receptor-binding domain (RBD), with heavy chain N53I enhancing binding and light chain tyrosines recognizing F486RBD. Despite these similarities, class members bound both RBD-up and -down conformations of the spike, with a subset of antibodies utilizing elongated CDRH3s to recognize glycan N343 on a neighboring RBD – a quaternary interaction accommodated by an increase in RBD separation of up to 12 Å. The VH1-2-antibody class thus utilizes modular recognition encoded by modular genetic elements to effect potent neutralization, with VH-gene component specifying recognition of RBD and CDRH3 component specifying quaternary interactions.

Highlights

  • Determine structures of VH1-2-derived antibodies 2-43, 2-15, and H4 in complex with SARS-CoV-2 spike

  • Define a multi-donor VH1-2-antibody class with modular components for RBD and quaternary recognition

  • Reveal structural basis of RBD-up and RBD-down recognition within the class

  • Show somatic hypermutations and avidity to be critical for potency

  • Delineate changes in spike conformation induced by CDRH3-mediated quaternary recognition

Competing Interest Statement

DDH, YH, JY, LL, MSN and PW are inventors of a patent describing antibodies 2-43, 2-4, and 2-15 reported on here.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 11, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
Micah Rapp, Yicheng Guo, Eswar R. Reddem, Lihong Liu, Pengfei Wang, Jian Yu, Gabriele Cerutti, Jude Bimela, Fabiana Bahna, Seetha Mannepalli, Baoshan Zhang, Peter D. Kwong, David D. Ho, Lawrence Shapiro, Zizhang Sheng
bioRxiv 2021.01.11.426218; doi: https://doi.org/10.1101/2021.01.11.426218
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
Micah Rapp, Yicheng Guo, Eswar R. Reddem, Lihong Liu, Pengfei Wang, Jian Yu, Gabriele Cerutti, Jude Bimela, Fabiana Bahna, Seetha Mannepalli, Baoshan Zhang, Peter D. Kwong, David D. Ho, Lawrence Shapiro, Zizhang Sheng
bioRxiv 2021.01.11.426218; doi: https://doi.org/10.1101/2021.01.11.426218

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (2410)
  • Biochemistry (4763)
  • Bioengineering (3307)
  • Bioinformatics (14599)
  • Biophysics (6598)
  • Cancer Biology (5138)
  • Cell Biology (7387)
  • Clinical Trials (138)
  • Developmental Biology (4328)
  • Ecology (6834)
  • Epidemiology (2057)
  • Evolutionary Biology (9854)
  • Genetics (7317)
  • Genomics (9478)
  • Immunology (4515)
  • Microbiology (12603)
  • Molecular Biology (4907)
  • Neuroscience (28142)
  • Paleontology (198)
  • Pathology (799)
  • Pharmacology and Toxicology (1373)
  • Physiology (2000)
  • Plant Biology (4458)
  • Scientific Communication and Education (970)
  • Synthetic Biology (1293)
  • Systems Biology (3896)
  • Zoology (719)